询 单
请 填 写 相 关 信 息
产品信息
产品名称
别名
CAS号
结构式 上传
联系方式
公司
联系人
电话
邮箱
内容
提交
中文版 English
请输入产品名称、CAS式、分子式
2'-Nitro-5'-fluoroacetophenone | CAS:2250-48-8
2'-Nitro-5'-fluoroacetophenone
  • 名称:2'-硝基-5'-氟苯乙酮 | 2'-Nitro-5'-fluoroacetophenone
  • CAS号:2250-48-8
  • 别名:3-Fluoro-6-nitroacetophenone
  • 分子式:C8H6FNO3
  • 分子量:183.14
  • EINESC号:

产品描述

物理化学性质

密度 1.336±0.06 g/cm3 (20 º

安全数据

没有数据没有数据

SDS

来源 SDS样本
没有数据没有数据
产品合成路线
更多

名称 CAS号
更多
文章
同行评议文献
[Study report: Hypertension therapy with organ protection. Piretanid and Ramipril: advantages with fixed combination]. Fortschritte der Medizin. Supplement : die Kongressinformation fur die Praxis, 164, 3-15 (1994-01-01) Effect of Na/K/2Cl transporter inhibition with piretanide on postischemic kidney function.D Abendroth et al.Transplantation proceedings, 28(1), 83-84 (1996-02-01) Piretanide. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.S P Clissold et al.Drugs, 29(6), 489-530 (1985-06-01) Peripheral and central antinociceptive action of Na+-K+-2Cl- cotransporter blockers on formalin-induced nociception in rats.Vinicio Granados-Soto et al.Pain, 114(1-2), 231-238 (2005-03-01) [Profile of the action of diuretics. Piretanide in comparison with thiazides and anti-kaliuretic drugs].H Knauf et al.Der Internist, 33 Suppl 1, S16-S22 (1992-08-01) Piretanide: a loop-active diuretic. Pharmacology, therapeutic efficacy and adverse effects.J D Marsh et al.Pharmacotherapy, 4(4), 170-180 (1984-07-01) [Prevention of ischemia before cold ischemia by pharmcologic donor conditioning--experimental findings].R Prestel et al.Langenbecks Archiv fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft fur Chirurgie. Kongress, 115(Suppl I), 659-663 (2003-10-02) Determination of piretanide and furosemide in pharmaceuticals and human urine by high-performance liquid chromatography with amperometric detection.M B Barroso et al.Journal of chromatography. B, Biomedical applications, 675(2), 303-312 (1996-01-26) [Cytolytic hepatic lesion associated with the ingestion of piretanide].G Bellaïche et al.Gastroenterologie clinique et biologique, 19(4), 444-445 (1995-04-01) A pentylenetetrazole-induced generalized seizure in early life enhances the efficacy of muscarinic receptor coupling to G-protein in hippocampus and neocortex of adult rat.Soizic Potier et al.The European journal of neuroscience, 21(7), 1828-1836 (2005-05-05) Fc epsilon RI-mediated chloride uptake by rat mast cells: modulation by chloride transport inhibitors in relation to histamine secretion.A C Redrup et al.British journal of pharmacology, 122(6), 1188-1194 (1997-12-24) Stability-indicating methods for the determination of piretanide in presence of the alkaline induced degradates.Nadia F Youssef Journal of pharmaceutical and biomedical analysis, 39(5), 871-876 (2005-10-15) [Comparative study, using a placebo, of the frequency of micturition after repeated administration of piretanide SR 6 mg/day (Eurelix) to healthy volunteers].R Genthon et al.Therapie, 50(1), 47-51 (1995-01-01) Calcitonin gene-related peptide receptors in human gastrointestinal epithelia.H M Cox et al.British journal of pharmacology, 113(4), 1243-1248 (1994-12-01) Buoyancy and drug release patterns of floating minitablets containing piretanide and atenolol as model drugs.N Rouge et al.Pharmaceutical development and technology, 3(1), 73-84 (1998-04-09) Modulation of chloride, potassium and bicarbonate transport by muscarinic receptors in a human adenocarcinoma cell line.N D Holliday et al.British journal of pharmacology, 126(1), 269-279 (1999-03-02) The bumetanide-resistant part of forskolin-induced anion secretion in rat colon.G Schultheiss et al.Acta physiologica Scandinavica, 164(2), 219-228 (1998-11-07) Differential regulation of collecting duct Na+, K+-ATPase and K+ excretion by furosemide and piretanide: role of bradykinin.Bénédicte Buffin-Meyer et al.Journal of the American Society of Nephrology : JASN, 15(4), 876-884 (2004-03-23) Increased (Na+K+Cl) cotransport in rat arterial smooth muscle in deoxycorticosterone (DOCA)/salt-induced hypertension.R A Brown et al.Journal of vascular research, 36(6), 492-501 (2000-01-12) Double-blind comparison of antihypertensive treatment with ramipril and piretanide, given alone or in combination.L Thijs et al.Journal of cardiovascular pharmacology, 26(1), 33-38 (1995-07-01) Na-K/2Cl transporter inhibition for reduction of postischemic kidney failure tested in autologous reperfusion.R Prestel et al.Transplant international : official journal of the European Society for Organ Transplantation, 9 Suppl 1, S437-S441 (1996-01-01) The Eurevie Study: contrasting effect of piretanide and thiazides in mild to moderate hypertension.O L Charansonney et al.Therapie, 52(3), 169-177 (1997-05-01) Role of EDHF in the vasodilatory effect of loop diuretics in guinea-pig mesenteric resistance arteries.F Pourageaud et al.British journal of pharmacology, 131(6), 1211-1219 (2000-11-18) Micellar electrokinetic chromatography as a fast screening method for the determination of the doping agents furosemide and piretanide in urine.S P Lalljie et al.Journal of chromatography. B, Biomedical sciences and applications, 688(1), 71-78 (1997-01-10) Pharmacokinetics and pharmacodynamics of ramipril and piretanide administered alone and in combination.G Ruf et al.European journal of clinical pharmacology, 46(6), 545-550 (1994-01-01) Rat NKCC2/NKCC1 cotransporter selectivity for loop diuretic drugs.P Hannaert et al.Naunyn-Schmiedeberg's archives of pharmacology, 365(3), 193-199 (2002-03-08) Usefulness of piretanide plus ramipril for systemic hypertension: a multicenter trial.V Homuth et al.The American journal of cardiology, 72(9), 666-671 (1993-09-15) Mode of interaction of loop diuretics with human serum albumin and characterization of binding site.N Takamura et al.Pharmaceutical research, 13(7), 1015-1019 (1996-07-01)
备注

Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).

名称 CAS号

相关产品

相关资讯

热门标签
询 单
请 填 写 相 关 信 息
产品信息
产品名称
别名
CAS号
结构式 上传
联系方式
公司
联系人
电话
邮箱
内容
提交